The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeplat Energy Regulatory News (SEPL)

Share Price Information for Seplat Energy (SEPL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.00
Bid: 171.00
Ask: 173.50
Change: 0.00 (0.00%)
Spread: 2.50 (1.462%)
Open: 172.00
High: 173.00
Low: 172.00
Prev. Close: 172.00
SEPL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of the Global Offer over-allotment option

29 Apr 2014 13:45

RNS Number : 7868F
SEPLAT Petroleum Development Co PLC
29 April 2014
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE

This announcement is an advertisement and not a prospectus. Investors should not purchase or subscribe for any securities referred to in this announcement. This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United Kingdom, the United States or any other jurisdiction.

 

SEPLAT Petroleum Development Company Plc

Exercise of the Global Offer over-allotment option

London and Lagos: 29 April 2014: SEPLAT Petroleum Development Company Plc ("SEPLAT" or the "Company" including its subsidiaries), an indigenous independent oil and gas company incorporated and operating in Nigeria with a strategic focus on Nigeria announces that the Joint Global Coordinators have today exercised the over-allotment option over 10,026,183 Ordinary Shares, representing 97% of the over-allotment option granted by the Company in connection with the Global Offer.

The Company will receive net proceeds (after fees and commissions) of approximately £20 million on the over-allotment option closing date on or around 6 May 2014.

BNP Paribas and Standard Bank plc are acting as joint global co-ordinators and joint bookrunners and Renaissance Securities (Cyprus) Limited, Citigroup Global Markets Limited and RBC Capital Markets are acting as joint bookrunners (together, the "Joint Bookrunners"). Renaissance Securities (Nigeria) Limited and Stanbic IBTC Capital Limited have been appointed as Nigerian joint issuing houses in relation to the Nigerian Offering.

Enquiries

SEPLAT Petroleum Development Company Plc

Roger Brown, Chief Financial Officer

David Boyd, Investor Relations

Chioma Nwachuku, GM - Corporate Affairs & Business Development

 

 

+44 203 725 6500

+44 203 725 6500

+234 12 770 400

 

FTI Consulting

Ben Brewerton / Sara Powell / George Parker

 

+44 203 727 1000

seplat@fticonsulting.com

 

BNP Paribas

Florence Sztuder, Equity Syndicate Desk

Ben Canning, Equity Capital Markets

Marianne Daryabegui, Corporate Finance

 

 

+33 144 954 100

+44 207 595 2000

+33 142 98 1234

Standard Bank plc / Stanbic IBTC Capital Limited

Simon Matthews / Chris Godman / Yewande Sadiku

+44 203 145 8106

 +234 14 228 100

 

Renaissance Securities (Cyprus) Limited / Renaissance Securities (Nigeria) Limited

John Porter / Yvonne Ike

 

 

+44 207 367 8242

 +234 14 485 311

Citigroup Global Markets Limited

Tom Reid / Miguel Azevedo / Chris Bucknall / Samit Parekh

 

 

+44 207 986 4000

RBC Europe Limited

Tim Chapman / Stephen Foss / Matthew Coakes / Jakub Brogowski

 

 

+44 207 653 4000

 

Important Notice

The contents of this announcement, which have been prepared by and are the sole responsibility of the Company, have been approved by BNP Paribas solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000.

 

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness.

 

This announcement is an advertisement and not a prospectus and investors should not subscribe for or purchase any shares referred to in this announcement.

 

This announcement is not for publication distribution, directly or indirectly, in or into the United States (as defined under Regulation S of the United States Securities Act of 1933, as amended (the "Securities Act"), Canada, Australia or Japan or any other jurisdiction in which the same would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in any jurisdiction. The ordinary shares of SEPLAT (the "Ordinary Shares") have not been, and will not be, registered under the Securities Act. The Ordinary Shares may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities Act. There will be no public offer of Ordinary Shares in the United States.

 

This announcement does not constitute an offer of securities to the public in the United Kingdom. This communication is being distributed only to and directed only at (i) persons falling within Article 19(5) ("investment professionals") of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") who have professional experience in matters relating to investments, (ii) high net worth persons falling within Article 49(2)(a) to (d) of the Order and/or (iii) any other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "relevant persons"). This announcement must not be acted on or relied on by any person who is not a relevant person. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

 

This announcement is distributed in any member state of the European Economic Area which applies the Prospectus Directive (this Directive together with any implementing measures in any member state, the "Prospectus Directive") only to those persons who are qualified investors for the purposes of the Prospectus Directive in such member state, and such other persons as this document may be addressed on legal grounds, and no person that is not a relevant person or qualified investor may act or rely on this document or any of its contents. The expression "Prospectus Directive" means Directive 2003/71/EC (and any amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State) and includes any relevant implementing measure in each Relevant Member State, and the expression "2010 PD Amending Directive" means Directive 2010/73/EU.

 

The Ordinary Shares have not been and will not be offered or sold to the public in the Republic of France, and no offering or marketing materials relating to the Ordinary Shares must be made available or distributed in any way that would constitute, directly or indirectly, an offer to the public in the Republic of France.

 

The Ordinary Shares may only be offered or sold in the Republic of France pursuant to article L. 411-2-II of the French Code monétaire et financier to (i) providers of third-party portfolio management investment services, (ii) qualified investors (investisseurs qualifiés) acting for their own account, all as defined in and in accordance with articles L. 411-1, L. 411-2 and D. 411-1 and D. 411-4 of the French Code monétaire et financier.

 

No reliance may or should be placed by any person for any purposes whatsoever on the information contained in this announcement or on its completeness, accuracy or fairness. The information in this announcement is subject to change.

 

This announcement does not constitute a recommendation concerning the Global Offer. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. Information in this announcement or any of the documents relating to the Global Offer cannot be relied upon as a guide to future performance. Potential investors should consult their professional advisors as to the suitability of the Global Offer for the persons concerned.

 

This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond the Company's control and all of which are based on the Company's current beliefs and expectations about future events. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth, strategies and the oil and gas business. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance.

 

Each of the Joint Bookrunners is regulated in the UK by the Financial Conduct Authority and is acting exclusively for the Company and no one else in connection with the Global Offer and will not regard any other person as its client in relation to the Global Offer and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for giving advice in relation to the Global Offer or the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

None of the Joint Bookrunners or any of their respective subsidiary undertakings, affiliates or any of their respective directors, officers, employees, advisers, agents or any other person accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to the truth, accuracy, completeness or fairness of, the information or opinions in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

 

Certain figures contained in this announcement, including financial information, have been subject to rounding adjustments. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this announcement may not conform exactly with the total figure given.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCILMTTMBITBJI
Date   Source Headline
13th Mar 20187:00 amRNSSuccessful $300 million RCF refinancing
13th Mar 20187:00 amRNSAnnouncement of $350 million Bond Pricing
9th Mar 20185:00 pmRNSNotification of Share Dealings by PDMRs
28th Feb 201811:34 amRNSLaunch of U.S. Dollar denominated bond offering
28th Feb 20187:00 amRNSFull Year 2017 Financial Results
26th Feb 201810:19 amRNSAppointment of Executive Operations Director
26th Feb 20188:49 amRNSNotice of Results
2nd Feb 20187:00 amRNSVoting Rights and Issued Share Capital
23rd Oct 20177:00 amRNSInterim Management Statement & Q3 2017 Results
27th Jul 20177:00 amRNSConsolidated Half-Yearly Financial Results
24th Jul 20177:00 amRNSNotice of Half Yearly Results
3rd Jul 20177:00 amRNSOne year extension of revolving credit facility
19th Jun 20178:20 amRNSHolding(s) in Company
7th Jun 201712:10 pmRNSOperations update
2nd Jun 201710:04 amRNSResult of AGM
30th May 20177:00 amRNSHolding(s) in Company
28th Apr 20177:00 amRNSInterim Management Statement & Q1 2017 Results
26th Apr 20177:00 amRNS2016 Annual Report and Notice of AGM
24th Apr 201712:56 pmRNSDirector/PDMR Shareholding
4th Apr 20175:26 pmRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSRetirement of Mr. Stuart Connal
30th Mar 20177:00 amRNSFull Year 2016 financial results
23rd Mar 20177:00 amRNSNotice of Full Year 2016 Financial Results
3rd Feb 20172:24 pmRNSHolding(s) in Company
27th Jan 20173:02 pmRNSHigh Court Proceedings
17th Jan 201710:04 amRNSDirector/PDMR Shareholding
29th Dec 20169:04 amRNSPDMR Notification
21st Nov 20165:57 pmRNSHolding(s) in Company
27th Oct 20167:00 amRNSInterim Management Statement & Q3 2016 Results
31st Aug 20164:40 pmRNSSecond Price Monitoring Extn
31st Aug 20164:35 pmRNSPrice Monitoring Extension
28th Jul 20167:00 amRNSConsolidated Half-Yearly Financial Results
25th Jul 20162:38 pmRNSNotice of Results
30th Jun 201611:48 amRNSReport on Payments to Governments
2nd Jun 20164:19 pmRNSResult of AGM
31st May 20164:35 pmRNSPrice Monitoring Extension
20th May 201611:57 amRNS2015 Final Dividend Currency Exchange Rates
29th Apr 20167:04 amRNSInterim Management Statement & Q1 2016 Results
28th Apr 20166:06 pmRNSPublication of 2015 Annual Report & Notice of AGM
12th Apr 201611:41 amRNS2015 Final Dividend
24th Mar 20164:01 pmRNSNotification of Transactions by DMRs
24th Mar 20167:00 amRNSFull year 2015 financial results
22nd Mar 20167:00 amRNSNotice of full year 2015 financial results
29th Jan 20164:40 pmRNSSecond Price Monitoring Extn
29th Jan 20164:35 pmRNSPrice Monitoring Extension
29th Jan 20164:24 pmRNSSeplat takes over operatorship of OML53 and OML55
25th Jan 20167:00 amRNSTrading Statement and Operations Update
10th Nov 201510:09 amRNSHolding(s) in Company
6th Nov 20153:11 pmRNSVoting Rights and Issued Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.